Skip to content

Effectiveness of Perineorrhaphy in Pelvic Organ Prolapse Surgery

Effectiveness of Perineorrhaphy in Pelvic Organ Prolapse Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07006129
Acronym
PINPOPS
Enrollment
40646
Registered
2025-06-05
Start date
2007-01-01
Completion date
2022-12-31
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse (POP), Pelvic Organ Prolapse Vaginal Surgery

Keywords

Target Trial Emulation, Pelvic organ prolapse, Perineorrhaphy, Vaginal surgery, Cystocele, Rectocele, Apical prolapse

Brief summary

This is an observational registry-based study of long-term outcome after vaginal native tissue repair for pelvic organ prolapse designed to emulate a pragmatic open-label two-arm trial for which patients, in whom perineorrhaphy is not strictly indicated but clinically tenable, perioperatively are randomized to concomitant perineorrhaphy or not.

Detailed description

This is an emulated pragmatic open-label two-arm trial in patients undergoing native tissue repair surgery for pelvic organ prolapse, in which patients are randomized perioperatively to either concomitant perineorrhaphy or not. The target population is the large group of patients for whom, at the discretion of the surgeon, this intervention is currently an option while not being strictly indicated. The investigators assumed that women were randomly assigned perioperatively to either strategy within levels of baseline co-variables: age, BMI, parity, lung disease, ASA-classification, constipation, hypermobility, prolapse in which vaginal compartment and if surgery is performed on it, year of primary surgery and region. Data was obtained from The Swedish National Quality Register of Gynaecological Surgery (GynOp), the Swedish National Patient Register, the Swedish Medical Birth Register, and the Swedish Cause of Death Register. In order to emulate a target trial, multiple imputation of missing data is followed by controlling for confounding through inverse probability weighting (IPW) in order to estimate the average treatment effect (ATE) in the primary analysis. In the secondary analysis, the primary analysis will be repeated but with overlap weights. Additional analyses: The sample will be re-weighted using IPW to estimate the average treatment effect on the treated (ATT). Restricted mean survival time (RMST) will be calculated at five years of follow-up for the primary outcome. Bias analysis: Mortality during follow up for the primary outcome will be used as a negative control.

Interventions

Concomitant perineorrhaphy

No concomitant perineorrhaphy

Sponsors

Lund University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Pelvic organ prolapse surgery with vaginal native tissue repair without concomitant hysterectomy.

Exclusion criteria

* Primary surgery with colpocleisis, use of mesh, laparoscopic or abdominal surgery, concomitant incontinence surgery (eg transvaginal tape). * Previous hysterectomy * Previous pelvic organ prolapse surgery

Design outcomes

Primary

MeasureTime frameDescription
Reoperation5 yearsReported as absolute risk difference, with cumulative risks during five years of follow-up estimated using the Kaplan-Meier estimator. Data obtained from the The Swedish National Quality Register of Gynaecological Surgery (GynOp) and the Swedish National Patient Register.

Secondary

MeasureTime frameDescription
Symptoms of a vaginal bulge (patient reported outcome)At 1 yearAbsolute risk difference for the outcome at 1 year follow-up with the non-inferiority margin set to 10% of the absolute risk in the comparison group. Data obtained from the The Swedish National Quality Register of Gynaecological Surgery (GynOp).
Unsatisfied (patient reported outcome)At 1 yearAbsolute risk difference for the outcome at 1 year follow-up with the non-inferiority margin set to 10% of the absolute risk in the comparison group. Data obtained from the The Swedish National Quality Register of Gynaecological Surgery (GynOp).

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026